As of 2025-06-13, the Intrinsic Value of Prestige Consumer Healthcare Inc (PBH) is 105.01 USD. This PBH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 85.12 USD, the upside of Prestige Consumer Healthcare Inc is 23.40%.
The range of the Intrinsic Value is 71.69 - 187.13 USD
Based on its market price of 85.12 USD and our intrinsic valuation, Prestige Consumer Healthcare Inc (PBH) is undervalued by 23.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 71.69 - 187.13 | 105.01 | 23.4% |
| DCF (Growth 10y) | 83.53 - 200.13 | 117.45 | 38.0% |
| DCF (EBITDA 5y) | 64.18 - 108.29 | 77.96 | -8.4% |
| DCF (EBITDA 10y) | 76.32 - 124.56 | 92.14 | 8.2% |
| Fair Value | 108.58 - 108.58 | 108.58 | 27.57% |
| P/E | 81.83 - 130.30 | 105.94 | 24.5% |
| EV/EBITDA | 59.64 - 239.46 | 120.01 | 41.0% |
| EPV | 65.86 - 93.43 | 79.65 | -6.4% |
| DDM - Stable | 41.60 - 123.75 | 82.68 | -2.9% |
| DDM - Multi | 50.27 - 117.98 | 70.71 | -16.9% |
| Market Cap (mil) | 4,205.78 |
| Beta | 0.41 |
| Outstanding shares (mil) | 49.41 |
| Enterprise Value (mil) | 5,123.37 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.23% |
| Cost of Debt | 4.56% |
| WACC | 6.52% |